Daniel Medeiros Biomedical Engineering. Problem  2009: 154,324 patients waiting for organs 27,996 patients received them (18%)  8,864 patients died.

Slides:



Advertisements
Similar presentations
Medical Biotechnology Regenerative Medicine
Advertisements

… tissue on demand for unmet medical needs Methuselah Foundation Webinar June 10, 2009 Private Presentation CONFIDENTIAL This report is solely for the.
REGENERATIVE MEDICINE
By Anthony Catalano. The Extracellular Matrix (ECM) Provides support to tissue Composed of fibers: Collagen and Elastin Made up of cells called Fibroblasts.
Organ Printing Vi Tran BME 181 April 1, The Need For Organs Today -117,521 people in United States in need of organ according to organdonor.gov.
Tissue Engineering By: Cassie Kuchta & Tim Rohman.
Tissue Engineering By Michael DaSilva.
Celeste Riley Mentor: Dr. Robert Peattie
ARTIFICIAL TISSUES AND SCAFFOLDING A BME 281 presentation by: Zachary Brown.
3D Printed Tracheal Graft: Early Results in a Porcine Model Faiz Bhora, MD, FACS Chief Thoracic Surgery Co-Director Airway Center Mount Sinai St. Luke’s.
CRICOS: 00116K Biomedical Engineer: Design products and procedures that solve medical problems. These include artificial organs, prostheses, instrumentation,
Organ Printing Callie Thomas BME 281 Fall The Organ Waitlist According to Organdonor.gov, there are 115,476 people in the U.S. alone on the waiting.
SKIN GRAFTING: A BIOMEDICAL ENGINEERING PURSUIT BRYAN LINDLEY.
3D Printing Organs Taryn Mingey. Why would do we need to 3D print organs?  The number of patients in need of transplants has risen signifgantly since.
The Biotechnology Center of Excellence Bringing Biotech from the Bench to the K-12 Classroom Event: Regenerative Medicine Webinar Date: May 22, 2014, 4pm.
Robert Farley Biomedical Engineering.  Engineered blood vessels made from autologous cells  Autologous cells – cells used to build the vessels are extracted.
OLIVIA DAVIS Can Stem Cells Be Used To Grow Replacement Parts?
BioSciencs Foro November 8th, New York Joaquin Guinea Chairman of BIOMADRID (
Health Biotechnology Stem Cell Therapeutics; Tissue Engineering LECTURE 21: Biotechnology; 3 Credit hours Atta-ur-Rahman School of Applied Biosciences.
Presented by: SELFIE. The demand for body parts and organ transplant exceeds the number of available donors. According to Biotechnology Industry Organization.
Tissue Engineering By: Chris Morino University of Rhode Island, Biomedical Engineering, BME 181.
Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University.
An Introduction to the GO Database, STRING Database, and Stem Cells Jay Concepcion, Jacob McCaa, and Mason Rasmussen.
The Bio-Printer: 3-D Organ Printing Leah Acquaviva BME 281 Fall 2014.
BIOENGINEERING BODY PARTS AND ORGANS FOR TRANSPLANT
Tissue Engineering Reagan Coats. Organ Transplantation In the United States, the number of patients on the waiting list rose to over 95,000 in the year.
Cell Differentiation – Stem Cells how specialized cells get produced controlled by the cell’s DNA stem cells are animal cells that can differentiate into.
Tanya Wang URI Department of Biomedical Engineering April 28 th, 2010 Professor Ying Sun.
Muhammad Adeel Faiza Asghar Amina Shakarullah. What is Regenerative Medicine? Adeel What is the Current Perspectives and Therapeutic Potential of Regenerative.
1.Disease: heart, kidney, liver 2.Trauma 3.Environment: x-rays, 2 nd hand smoke 4. Aging 5.Congenital Defects: cleft palate, heart.
Biological Properties ISSUES TO ADDRESS... Biomaterials definition Different types of interaction between body and foreign material What are main characteristics.
3D Bioprinting For Cartilage
Ila Saunders, PharmD, BCOP Research Interests Impact of clinical pharmacy services in a matrix cancer center Impact of a “Transitions of Care” clinical.
STEM CELLS.  Where do the different cells and tissues in your body come from?  Incredible as it seems, every cell was produced by mitosis from a small.
pictures_slideshow/article.htm.
 first human genome draft.  July 2 nd, AbioCor, an artificial heart(founded in 1987), was approved by the FDA.  February 12 th, human.
By: Kristen Kinchla, Elisabeth Smith, Matt Downs.
Human Artificial Body Parts By: Daren Oakeson. What Do We Know So Far?  Body processes are at the molecular level.  Surface area to volume ratio makes.
Structure Hollowed out cylinder made from polycarbonate Screw-on cap fitted with rubber gasket to prevent leaking Twist-down compressor rod Sized to fit.
Regenerative Medicine Regenerative medicine~ Goal: to grow replacement tissue or organs for patients who have sustained an injury or have a disease that.
EnvironmentScaffolds Stem Cells Tissue Engineering & Regenerative Medicine.
REGENERATIVE MEDICINE BIOMEDICAL TECHNOLOGY 1. Regenerative medicine is growing replacement tissue or organs for patients who have sustained an injury.
Bone Marrow Donation. What is Bone marrow?  flexible spongy tissue in the interior of bones such as your hip and thigh.  constitutes 4% of the total.
Mathematical Calculations Superior Storage of Information Cross-referencing.
Regenerative Medicine Regenerative medicine~ Goal: to grow replacement tissue or organs for patients who have sustained an injury or have a disease that.
Silk, Scaffolds, and Stem Cells
Magnetic levitation in 3D printing for healthcare market to grow substantially to 2024
Problem How to manipulate material on a nano scale effectively?
Chemical and Biomedical Engineering
Samira M. Azarin, Sean P. Palecek  Cell Stem Cell 
Tissue/Organ Engineering
Regenerative Medicine
Regenerative Medicine
By Tyler Gagan BME 281 Section 2
Regenerative Medicine
Figure 7 Treatment algorithm for perianal fistulizing disease
Could 3D bioprinted tissues offer future hope for microtia treatment?
3D Bioprinting For Cartilage
Figure 5 Two approaches to therapeutic genome editing
Tissue engineering of reproductive tissues and organs
POSEIDON-DCM Trial design: Patients with nonischemic dilated cardiomyopathy were randomized to transendocardial injection of allogenic (n = 18) vs. autologous.
REGENERATIVE MEDICINE
Regenerative Medicine
CD133+ cells: How could they have an IMPACT?
Nat. Rev. Cardiol. doi: /nrcardio
LEARN ABOUT OUR PURPOSE & COMITTMENT TO IMPROVING PATIENT QUALITY OF LIFE Skye Biologics, a U.S.-based leader in biotechnology, was founded in 2006 to.
Development of bioink for 3D printing applications in tissue engineering Supachai Reakasame Institute of Biomaterials, FAU Erlangen-Nuremberg,
1. Identify the tissue.
Figure 1 3D printing techniques
Every 30 seconds, a patient dies from diseases that could be treated with tissue replacement 3D Printing Organs.
Presentation transcript:

Daniel Medeiros Biomedical Engineering

Problem  2009: 154,324 patients waiting for organs 27,996 patients received them (18%)  8,864 patients died waiting Approx. 25 people per day  Cost of surgery & follow up procedures in 2012: $300 billion  Tissue Rejection & Immunosuppressants

3D Printing  “Sterolithography”  Present day: $700 million industry $11 million invested in medical applications (1.6%)  Next 10 years: $8.9 billion industry $1.9 billion invested in medical applications (21%)

Typical Process for Bioprinting Murphy, Sean V., and Anthony Atala. "3D Bioprinting of Tissues and Organs." Nat Biotechnol Nature Biotechnology 32.8 (2014): Web.

Design Approaches  Mini-Tissues  Biomimicry  Self-Assembly

Material/Cell Selection  Synthetic Polymers, Natural Polymers, Extracellular Matrix  Differentiated Cells & Stem Cells Allogenic v.s Autologous

Discussion  Need  Money  Speed/Time  Biocompatibility  Complexity